Alexion Pharm Inc (ALXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,010,000 | 943,999 | 529,857 | 989,501 | 540,865 |
| Marketable Securities | 375,000 | 1,017,567 | 984,994 | N/A | N/A |
| Receivables | 533,000 | 432,888 | 421,752 | 295,598 | 244,288 |
| Inventories | 290,000 | 176,441 | 102,602 | 94,521 | 81,386 |
| Income taxes - deferred | N/A | N/A | 41,432 | 26,086 | 19,132 |
| TOTAL | $2,416,000 | $2,796,029 | $2,186,857 | $1,495,600 | $941,270 |
| Non-Current Assets | |||||
| PPE Net | 697,000 | 392,248 | 201,109 | 165,629 | 165,852 |
| Intangibles | 9,756,000 | 841,119 | 863,792 | 900,323 | 171,243 |
| Other Non-Current Assets | 228,000 | 172,566 | 65,938 | 52,008 | 116,386 |
| TOTAL | $10,681,000 | $1,405,933 | $1,130,839 | $1,117,960 | $453,481 |
| Total Assets | $13,097,000 | $4,201,962 | $3,317,696 | $2,613,560 | $1,394,751 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 166,000 | 48,000 | 48,000 | 48,000 | 0 |
| Accounts payable and accrued liabilities | 57,000 | 44,016 | 21,596 | 21,488 | 16,029 |
| Accrued Expenses | 403,000 | 395,232 | 402,344 | 249,787 | 183,624 |
| Other current liabilities | 6,000 | 60,655 | 56,688 | 9,548 | 10,227 |
| TOTAL | $709,000 | $606,740 | $582,429 | $360,089 | $227,785 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,254,000 | 9,500 | 65,000 | 101,000 | 0 |
| Deferred Revenues | 21,000 | 58,837 | 53,801 | 31,266 | 17,905 |
| Other Non-Current Liabilities | 195,000 | 169,559 | 154,717 | 161,794 | 32,471 |
| TOTAL | $4,129,000 | $293,204 | $353,188 | $282,621 | $32,474 |
| Total Liabilities | $4,838,000 | $899,944 | $935,617 | $642,710 | $260,259 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 225,291 | 202,149 | 197,830 | 195,209 | 185,993 |
| Common Shares | N/A | 20 | 20 | 20 | 19 |
| Retained earnings | 1,181,000 | 1,036,010 | 379,098 | 126,203 | -128,619 |
| Other shareholders' equity | 62,000 | 56,821 | -23,222 | 6,406 | 4,503 |
| TOTAL | $8,259,000 | $3,302,018 | $2,382,079 | $1,970,850 | $1,134,492 |
| Total Liabilities And Equity | $13,097,000 | $4,201,962 | $3,317,696 | $2,613,560 | $1,394,751 |